Top

The European Journal of Health Economics

Published in:

01-03-2007 | Original paper

Resource use and costs associated with patients treated for depression in primary care

Authors: P. Sobocki, M. Ekman, H. Ågren, I. Krakau, B. Runeson, B. Mårtensson, B. Jönsson

Published in: The European Journal of Health Economics | Issue 1/2007

Abstract

We investigated medical resource consumption, productivity loss and costs associated with patients treated with antidepressants for depression in primary care in Sweden. Patients on treatment for depression were followed naturalistically for six months, and data on patients’ characteristics, daily activity and resource-use were collected. The total cost per patient was estimated at € 5,500 (95%CI € 5,000—6,100) over six months in 2005 prices. Direct costs were estimated at € 1,900 (€ 1,700–2,200), 35% of total costs, and indirect costs at € 3,600 (€ 3,100–4,100), 65% of total costs. The cost for antidepressants represented only 4% of the total costs. We conclude that the burden of depression is high, both to the individual as well as to wider society, and there seems to be a particular need for therapies that have the potential to improve productivity in depressed patients.

Simon, G.E., Chisholm, D., Treglia, M., Bushnell, D.: Course of depression, health services costs, and work productivity in an international primary care study. Gen. Hosp. Psychiatry 24, 328–335 (2002)CrossRef

Andlin-Sobocki, P., Wittchen, H.U.: Cost of affective disorders in Europe. Eur. J. Neurol. 12(Suppl 1), 34–38 (2005)

Simon, G.E., Revicki, D., Heiligenstein, J., Grothaus, L., Von Korff, M., Katon, W.J., Hylan, T.R.: Recovery from depression, work productivity, and health care costs among primary care patients. Gen. Hosp. Psychiatry 22, 153–162 (2000)CrossRef

Guy, W.: ECDEU Assessment Manual for Psychopharmacology. National Institute of Mental Health, Rockeville (1976)

Hodgson, T.A., Meiners, M.R.: Cost-of-illness methodology: a guide to current practices and procedures. Milbank Meml. Fund. Q. Health Soc. 60, 429–462 (1982)CrossRef

Wackerly, D.D., Mendenhall, W., Schaeffer, R.L.: Mathematical statistics with applications. Duxbury, Belmont (1996)

Briggs, A., Gray, A.: Handling uncertainty when performing economic evaluation of health care interventions. Health Technol. Assess. 3, 35–60 (1999)

Gujarati, D.: Basic Econometrics. McGraw Hill, Singapore (1995)

Salize, H.J., Stamm, K., Schubert, M., Bergmann, F., Harter, M., Berger, M., Gaebel, W., Schneider, F.: Cost of care for depressive disorders in primary and specialized care in Germany. Psychiatr. Prax. 31, 147–156 (2004)

10.

Luber, M.P., Hollenberg, J.P., Williams-Russo, P., DiDomenico, T.N., Meyers, B.S., Alexopoulos, G.S., Charlson, M.E.: Diagnosis, treatment, comorbidity, and resource utilization of depressed patients in a general medical practice. Int. J. Psychiatr. Med. 30, 1–13 (2000)CrossRef

11.

Revicki, D.A., Simon, G.E., Chan, K., Katon, W., Heiligenstein, J.: Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment. J. Fam. Pract. 47, 446–452 (1998)

12.

Von Knorring, L., Åkerblad, A.C., Bengtsson, F., Carlsson, Å., Ekselius, L.: Cost of depression: effect of adherence and treatment response. Eur. Psychiatry 21(6):349–354 (2006)CrossRef

13.

Norinder, A., Nordling, S., Haggstrom, L.: Treatment of depression and cost efficiency. The cost of a tablet is a poor indicator seen from a socioeconomic perspective. Lakartidningen 97, 1693–1698, 1700 (2000)

14.

Henriksson, F., Jönsson, B.: Hälsoekonomiska aspekter på depressionssjukdomen. In: SBU (ed.) Behandling av depressionssjukdomar. En systematisk litteraturöversikt. SBU, Stockholm, pp 403–436 (2004)

15.

Greenberg, P.E., Kessler, R.C., Birnbaum, H.G., Leong, S.A., Lowe, S.W., Berglund, P.A., Corey-Lisle, P.K.: The economic burden of depression in the United States: how did it change between 1990 and 2000? J. Clin. Psychiatry 64, 1465–1475 (2003)CrossRef

16.

Peveler, R., Kendrick, T., Buxton, M., Longworth, L., Baldwin, D., Moore, M., Chatwin, J., Goddard, J., Thornett, A., Smith, H., Campbell, M., Thompson, C.: A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol. Assess. 9, 1–134, iii (2005)

17.

Rice, D.P., Miller, L.S.: The economic burden of affective disorders. Br. J. Psychiatry Suppl 27, 34–42 (1995)

18.

Thomas, C.M., Morris, S.: Cost of depression among adults in England in 2000. Br. J. Psychiatry 183, 514–519 (2003)CrossRef

19.

Isacsson, G.: Suicide prevention—a medical breakthrough? Acta Psychiatr. Scand. 102, 113–117 (2000)CrossRef

20.

Runeson, B., Wasserman, D.: Management of suicide attempters: what are the routines and the costs? Acta. Psychiatr. Scand. 90, 222–228 (1994)CrossRef

21.

Greenberg, P.F., Stiglin, L.E., Finkelstein, S.N., Berndt, E.R.: The economic burden of depression in 1990. J. Clin. Psychiatry 54, 405–418 (1993)

22.

Chisholm, D., Diehr, P., Knapp, M., Patrick, D., Treglia, M., Simon, G.: Depression status, medical comorbidity and resource costs. Evidence from an international study of major depression in primary care (LIDO). Br. J. Psychiatry 183, 121–131 (2003)CrossRef

23.

Simon, G.E., Barber, C., Birnbaum, H.G., Frank, R.G., Greenberg, P.E., Rose, R.M., Wang, P.S., Kessler, R.C.: Depression and work productivity: the comparative costs of treatment versus nontreatment. J. Occup. Environ. Med. 43, 2–9 (2001)CrossRef

24.

Simon, G.E., VonKorff, M.: Recognition, management, and outcomes of depression in primary care. Arch. Fam. Med. 4, 99–105 (1995)CrossRef

25.

Bingefors, K., Isacson, D., Knorring, L.V., Smedby, B., Wicknertz, K.: Antidepressant-treated patients in ambulatory care. Mortality during a nine-year period after first treatment. Br. J. Psychiatry 169, 647–654 (1996)CrossRef

26.

Sobocki, P., Jonsson, B., Angst, J., Rehnberg, C.: Cost of depression in Europe. J. Ment. Health Policy Econ. 9(2), 87–98 (2006)

Title: Resource use and costs associated with patients treated for depression in primary care
Authors: P. Sobocki
M. Ekman
H. Ågren
I. Krakau
B. Runeson
B. Mårtensson
B. Jönsson
Publication date: 01-03-2007
Publisher: Springer-Verlag
Published in: The European Journal of Health Economics / Issue 1/2007
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI: https://doi.org/10.1007/s10198-006-0008-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Resource use and costs associated with patients treated for depression in primary care

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2007

Long-term absenteeism due to sickness in Sweden. How long does it take and what happens after?

Cost of breast cancer in Sweden in 2002

Better primary physician services lead to fewer hospital admissions

A multilevel analysis on the determinants of regional health care expenditure: a note

Should we really worry about “launch delays” of new drugs in OECD countries?

Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set